首页> 外文OA文献 >Radiation Therapy Oncology Group 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin With Concurrent Radiotherapy for Patients With Locally Advanced Rectal Cancer

【2h】

Radiation Therapy Oncology Group 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin With Concurrent Radiotherapy for Patients With Locally Advanced Rectal Cancer

机译：放射治疗肿瘤组0247：随机阶段II研究Neoadjuvant Capecitabine和Irinotecan或Capecitabine和Oxaliplatin，并对当地晚期直肠癌患者进行同时放射治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Stuart J. Wong; Kathryn Winter; Neal J. Meropol; Pramila Rani Anne; Lisa Kachnic; Asif Rashid; James C. Watson; Edith Mitchell; Jondavid Pollock; Robert Jeffrey Lee; Michael Haddock; Beth A. Erickson; Christopher G. Willett;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Radiation therapy oncology group 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer [J] . WongS.J., WinterK., MeropolN.J., International Journal of Radiation Oncology, Biology, Physics . 2012,第4期

机译：放射治疗肿瘤学小组0247：新辅助卡培他滨和伊立替康或卡培他滨和奥沙利铂联合放射治疗的局部晚期直肠癌患者的II期随机研究
2. Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer [J] . Wong Stuart J., Moughan Jennifer, Meropol Neal J., International Journal of Radiation Oncology, Biology, Physics . 2015,第1期

机译：放射治疗的疗效终点小组协议0247：新辅助放射治疗联合并用卡培他滨和伊立替康或卡培他滨和奥沙利铂治疗局部晚期直肠癌的随机第二阶段研究
3. Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53 [J] . ChioreanE.G., SanghaniS., SchielM.A., Cancer chemotherapy and pharmacology. . 2012,第1期

机译：新辅助卡培他滨联合伊立替康联合基于卡培他滨的放化疗治疗局部晚期直肠癌的第二阶段和基因表达分析试验：Hoosier肿瘤学小组GI03-53
4. Neoadjuvant treatment in rectal cancer: do we always need radiotherapy-or can we risk assess locally advanced rectal cancer better? [C] . Rob Glynne-Jones St. Gallen EORTC Gastrointestinal Cancer Conference . 2012

机译：Neoadjuvant在直肠癌中治疗：我们总是需要放射治疗 - 或者我们是否可以更好地评估当地先进的直肠癌？
5. Efficacy Endpoints of RTOG 0247: A Randomized Phase II Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer [O] . Stuart J. Wong, J. Moughan, Neal J. Meropol, -1

机译：RTOG 0247的疗效终点：新辅助放疗联合卡培他滨和伊立替康或卡培他滨和奥沙利铂治疗局部晚期直肠癌的II期随机研究
6. Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer [O] . Stuart J. Wong, Jennifer Moughan, Neal J. Meropol, 2015

机译：放射治疗组协议的疗效终点0247：一种随机，第2期Neoadjuvant放射治疗加上当地晚期直肠癌患者的同时征征和伊替康或氧化甲醛和oxaliplatin

Radiation Therapy Oncology Group 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin With Concurrent Radiotherapy for Patients With Locally Advanced Rectal Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅